A-SPINE Asia Co., Ltd. (6758) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for A-SPINE Asia Co., Ltd. (6758:TWSE), powered by AI.

Current Price
$30.00
Sector
Healthcare
What is the A-SPINE Asia Co., Ltd. stock price forecast?

A-SPINE Asia Co., Ltd. is currently trading at $30.00. View real-time AI analysis on Alpha Lenz.

What is A-SPINE Asia Co., Ltd. insider trading activity?

View the latest insider trading data for A-SPINE Asia Co., Ltd. on Alpha Lenz.

What is A-SPINE Asia Co., Ltd.'s P/E ratio?

View A-SPINE Asia Co., Ltd.'s valuation metrics on Alpha Lenz.

A-SPINE Asia Co., Ltd.

TWSE · 6758
NT$30.00+0.00(+0.00%)
Ask about A-SPINE Asia Co., Ltd.'s future dividend policy...
Alpha Chat Insight

A-SPINE Asia Co., Ltd.'s ROE is 5.5%. Explore profitability and growth together.

Ask for details

Company Overview

A-SPINE Asia Co., Ltd. is a medical device manufacturer specializing in the research, development, production, and marketing of spinal implants and instruments. Established in 2001, it was the first company in Taiwan to focus exclusively on spine-related medical products, offering comprehensive treatment solutions such as spinal fixation systems, interbody fusion devices, vertebroplasty systems, and balloon kyphoplasty products. The company also acts as an agent for well-known imported orthopedic devices and provides original design and manufacturing (ODM/OEM) services for international brands, with a client base spanning Europe, Asia, and the Americas. A-SPINE Asia’s products are certified to international standards, including ISO 13485 and EU CE Mark, and are recognized for their strong postoperative safety records and clinical reliability. By closely collaborating with orthopedic specialists and academic institutions, the company continuously refines its product lines to meet the evolving demands of surgical practice and patient care. A-SPINE Asia holds a leading position in Taiwan’s spinal device sector and plays a significant role in advancing spine health management solutions across various global healthcare markets.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$448.80MRevenue
0.00Shares Out
0Employees

Margins

74.07%Gross
7.54%EBITDA
4.11%Operating
4.20%Pre-Tax
3.36%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

10.78%Rev 3Yr
3.94%Rev 5Yr
32.72%Op Inc 3Yr
-11.00%Op Inc 5Yr
23.49%Net Inc 3Yr
-13.08%Net Inc 5Yr

Returns

2.94%ROA
5.53%ROE
4.25%ROIC

Financial Health

NT$56.60MCash & Cash Equivalents
NT$188.53MNet Debt
89.33%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

A-SPINE Asia Co., Ltd. (ticker: 6758) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 30 with a P/E ratio of -x and P/B of -x.

ROE is 5.53% and operating margin is 4.11%. Annual revenue is $449M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
A-SPINE Asia Co., Ltd. (6758) Stock Forecast 2026 $30.00 — Price, Financials & Analyst Targets | Alpha Lenz